Gene Query: MRPS34

Dataset Description Geneva Score
miR941 overexpression experiment 72.06
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 35.38
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 31.76
Differential gene expression of human melanoma cells [RNA-seq] 31.76
Lysine benzoylation is a novel histone mark 31.27
Lysine benzoylation is a novel histone mark [RNA-seq] 31.27
Gene expression changes after LOC550643 silencing 28.2
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 27.18
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 27.18
RNA-seq in transgenic cells 26.99
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 25.7
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 23.77
NRDE2 negatively regulates nuclear exosome functions 23.07
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 22.45
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 22.12
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 22.12
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 22.0
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 21.78
Genetic-to-epigenetic Therapy for Pancreatic Cancer 21.7
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 21.7
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 21.61
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 21.19
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 20.14
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 19.26
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 18.98
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 18.83
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 18.83
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 18.17
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 18.17
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 17.89
Gene expression profiling of leukemia cells following asparagine depletion 17.76
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 17.34
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 17.16
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 16.39
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 16.38
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 16.1
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 16.06
Co-regulation of splicing by Rbfox1 and hnRNP M 16.06
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 15.97
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 15.89
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 15.78
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 15.49
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 15.31
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 15.31
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 15.26
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 14.83
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 14.82
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 14.78
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 14.76
Global analysis of enhancer targets: Mosaic-seq 14.67
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 14.66
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 14.55
The landscape of alternative splicing in aggressive prostate cancers 14.54
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 14.53
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 14.51
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 14.15
Effect of FGF13 depletion on the H460 cell line 14.12
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 14.11
IDH3a KO RNA-seq 14.09
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 14.09
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 13.87
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 13.8
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 13.8
RNA-seq analysis of RALD iPSCs after in vitro differentiation 13.71
Transcriptome analysis of U87 cells upon LINC00152 knockdown 13.71
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 13.67
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 13.67
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 13.54
A549 cells and MSR-A549 cells 13.49
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 13.49
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 13.46
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 13.4
Differentially expressed genes post knock down of lincDUSP26 13.35
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 13.31
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 13.31
The comparison of high-throughput single-cell RNA-seq methods 13.22
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 13.02
Identification of transcription start sites for human A549 cell line using ReCappable-seq 12.8
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 12.79
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 12.79
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 12.78
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 12.75
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 12.75
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 12.73
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 12.71
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 12.58
Genome wide expression change by RNF168 knocking down in NEC cells 12.54
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 12.53
High-throughput sequencing of pluripotent cells 12.51
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 12.46
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 12.46
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 12.44
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 12.34
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 12.23
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 12.19
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 12.11
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 12.02
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 11.92
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 11.85
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 11.7
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 11.7
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 11.19
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 11.14
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 11.05
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 11.05
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 11.05
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 11.02
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 10.88
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 10.85
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 10.83
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 10.82
Conservative alteration of chromosomal expression pattern across human solid tumor types 10.81
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 10.79
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 10.78
The evolution of N6-methyladenosine in primates 10.67
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 10.64
Impact of dieldrin on transcription in Jurkat T cells 10.63
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 10.58
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 10.58
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 10.58
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 10.54
Developmental stage specific chromosome architecture in human erythroid cells 10.54
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 10.52
U1 snRNP telescripting regulates size-function stratified human genome 10.48
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 10.43
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 10.42
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 10.42
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 10.41
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 10.41
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 10.26
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 10.2
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 10.2
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 10.16
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 10.12
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 10.03
N6-methyladenine DNA Modification in Glioblastoma 10.03
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 10.03
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 9.93
CROP-Seq in Primary Human T Cells 9.87
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 9.81
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 9.76
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 9.73
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 9.66
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 9.66
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 9.62
Gene expression analysis of dengue-infected cells 9.61
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 9.56
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 9.43
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 9.41
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 9.41
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 9.39
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 9.39
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 9.32
Total RNA-seq in ALL-SIL upon JQ1 inhibition 9.28
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 9.27
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 9.27
KLF6-dependent transcription in renal cancer cells 9.25
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 9.17
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 9.13
scRNASeq analysis of cycling cardiomyocytes 9.12
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 9.11
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 9.07
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 9.04
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 9.04
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 9.03
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 9.01
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 9.01
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 8.98
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 8.97
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 8.97
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 8.93
Effect of BB608 on Gene Expression in HNSCC Cell Line 8.92
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 8.92
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 8.92
Identification of HOXB13 target genes responsive to BET inhibitors 8.91
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 8.88
Human Treg IL-12 stimulation 8.88
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 8.78
Effect of Influenza virus infection on lncRNA expression in A549 cells 8.77
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.76
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 8.76
RNA-seq of resting and activated CD4+ T cells +-JQ1 8.75
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 8.74
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 8.73
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 8.7
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 8.7
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 8.64
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 8.62
Human cell line and subcutaneous tumor 8.62
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 8.53
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 8.44
RNA-seq analysis of differentiating human erythroblasts 8.44
Microprocessor mediates transcription termination in long noncoding microRNA genes 8.41
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 8.4
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 8.38
Comprehensive comparative analysis of 5’ end RNA sequencing methods 8.35
RNA seq with AML (NB4) cells upon FTO inhibition 8.34
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 8.32
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 8.3
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 8.28
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 8.27
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 8.24
Chromatin-informed inference of transcriptional programs in gynecologic cancers 8.24
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 8.24
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 8.24
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 8.21
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 8.21
RNA splicing alteration on glioblastoma and normal neural stem cells 8.2
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 8.13
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 8.12
An integrative analysis of non-coding regulatory DNA variations associated with autism 8.0
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 8.0
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.94
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 7.89
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 7.89
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 7.82
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 7.81
A Unique Epigenomic Landscape Defines Human Erythropoiesis 7.76
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 7.76
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 7.71
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 7.7
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 7.69
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 7.67
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 7.67
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 7.67
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 7.62
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 7.61
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 7.59
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 7.59
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 7.54
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 7.48
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 7.48
Peptidomimetic blockade of MYB in acute myeloid leukemia 7.47
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 7.47
HEK293 Heat-shock experiment 7.41
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 7.35
Human HAP1 cells before and after nutrient deprivation 7.35
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 7.31
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 7.3
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 7.26
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 7.25
Hijacking of stress response machinery by oncogenes in acute leukaemia 7.23
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 7.23
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 7.22
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 7.21
A map of gene expression in neutrophil-like cell lines 7.21
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 7.2
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 7.2
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 7.19
RNA-seq of YB5 cells treated with Proscillaridin A 7.18
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.17
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 7.14
Role of XRN2 ribonucleolytic activity in RNA metabolism 7.14
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.08
SUV420H2 knockdown in PANC-1 7.06
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 7.05
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 7.04
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 7.02
Expression and functions of long noncoding RNAs during human T helper cell differentiation 7.01
RNA seq comparison between scrambled and shGRP78 cells 6.97
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 6.95
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 6.95
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 6.95
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 6.95
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 6.94
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 6.93
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 6.85
Tracking distinct RNA populations using efficient and reversible covalent chemistry 6.81
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 6.77
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 6.65
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 6.63
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 6.56
Genome wide miR-191 target profile determined by RIP and gene expression profiling 6.56
RNA-Seq with and without RNase treatment in PCa cell lines 6.52
Generating Patterned Kidney Organoids for Studying Development and Diseases 6.45
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 6.43
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 6.42
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 6.42
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.36
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 6.3
Functional role of CPPED1 in trophoblasts. 6.2
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 6.17
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 6.15
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 6.14
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 6.14
Illumina Total RNA-seq in HeLa 6.12
SLAM-seq for K562 endogenous mRNA decay 6.12
Aneuploidy-induced cellular stresses limit autophagic degradation. 6.1
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 6.07
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 6.06
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 6.02
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 6.01
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 5.95
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 5.95
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 5.89
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 5.88
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 5.87
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 5.84
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 5.8
Proteomics identifies a marker signature of MAPKi resistance in melanoma 5.79
PRDM1 inhibits proliferation of human colon cancer organoids 5.77
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 5.76
METTL3 and WTAP 5.73
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 5.69
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.63
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 5.63
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 5.57
The cohesin complex prevents Myc-induced replication stress 5.56
Ectoderm specification of H1 human embryonic stem cells 5.51
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 5.44
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 5.37
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.37
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.36
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 5.35
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 5.29
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 5.28
Energy Metabolism during Anchorage-Independence 5.25
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 5.22
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.22
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 5.18
hnRNP C is a key regulator of protein synthesis in mitosis 5.14
Lineage specific differentiation is influenced by state of human pluripotency 5.06
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 5.06
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 5.03
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 5.01
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 4.99
Differential Protein Occupancy Profiling of the mRNA Transcriptome 4.96
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 4.95
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 4.92
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 4.91
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.76
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 4.65
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 4.62
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 4.61
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 4.61
Ro60-knockout cells 4.59
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 4.49
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 4.45
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 4.41
miRNAs affected by antagomiR-17 treatment 4.37
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 4.37
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.33
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 4.28
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 4.21
Loss of CREBBP results in gene expression repression in lymphoma cells 4.2
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 4.2
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 4.19
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 4.13
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 4.13
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 4.13
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.09
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.09
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 4.06
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.94
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.93
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.93
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.8
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 3.79
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 3.79
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.76
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.76
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 3.72
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.66
RNA editing in nascent RNA affects pre-mRNA splicing 3.66
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.66
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 3.65
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.64
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.62
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.62
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.61
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.54
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.5
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 3.5
m6A-dependent regulation of messenger RNA stability 3.48
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 3.45
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 3.45
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.41
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 3.4
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 3.36
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 3.33
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 3.32
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.32
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 3.32
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 3.32
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.32
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 3.29
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 3.29
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 3.25
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 3.25
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 3.24
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 3.16
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 3.13
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 3.1
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 3.03
Regulation of hypoxia-inducible factor activity by ZMYND8 3.01
RNAseq of cell lines with knocked in ESR1 mutations 2.91
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 2.89
Transcriptome analysis upon C6orf203 silencing 2.87
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 2.86
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 2.79
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 2.78
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 2.75
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 2.75
RNA-seq analysis upon ARID1B overexpression 2.65
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.62
TT-Seq captures the human transient transcriptome 2.61
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 2.6
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.58
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 2.56
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 2.53
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 2.47
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 2.46
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.43
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.39
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.39
Global transcriptome analysis of WT versus HEB-/- hESCs 2.38
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 2.38
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 2.33
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.32
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.31
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.26
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.1
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 2.08
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.99
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.91
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 1.91
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.9
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.9
Profiling of escape kinetics of viruses subjected to RNAi 1.8
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 1.74
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 1.74
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 1.71
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 1.71
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 1.68
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.66
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.64
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.64
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.61
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 1.55
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.43
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 1.41
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 1.39
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.35
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.33
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.31
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.31
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.29
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.23
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.19
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.13
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.08
SRSF1 role in cellular gene expression and splicing 1.07
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.05
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.05
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.03
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.0
The DPYSL2 gene connects mTOR and schizophrenia 0.94
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 0.93
Single-cell analysis of human kidney organoids 0.93
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.89
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.89
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.83
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.74
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.74
Transcriptome sequencing of K-562 cells 0.68
Impact on erythroid progenitor type on erythroid differntiation 0.65
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.62
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.55
Comparative Analysis of Cas9 Activators Across Multiple Species 0.55
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.54
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 0.53
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.52
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.45
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 0.43
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.42
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.4
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.39
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 0.37
MYCi975 regulates MYC target genes 0.37
Iron response of HepG2 cells 0.35
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.33
Enhancer activation during EGF response 0.33
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.31
Expression profiling of MCF-7 cells with treatment of TCDD 0.31
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.31
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.26
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.24
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.24
ChIP-seq and RNA-seq from human lymphoma cell lines 0.22
RNA-seq data from human lymphoma cell lines 0.22
The role of m6A/m-RNA methylation in stress response regulation 0.21
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.21
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.18
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.15
Genome-wide analysis of the Integrator complex (HTS) 0.12
Genome-wide analysis of the Integrator complex 0.12
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.08
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.08
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation